| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.4 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.045 | 0.4 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.4 |